Public-registry trials using Latanoprost 0.005% eye drops that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension | ViSci Ltd. | Open Angle Glaucoma | PHASE1 / PHASE2 | 1 |
| First registered study | October 2003 — NCT00069706 (Alcon Research) |
| Registered studies matching this name | 125 all-time · 6 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Trialed alongside
← Eichor home · All tracked trials · Open Angle Glaucoma studies · Weekly briefs